Dry Needling Effectiveness and Post-punction Pain
Launched by UNIVERSIDAD REY JUAN CARLOS · Oct 30, 2019
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
All patients suffered from mechanical neck pain and were randomized into three groups of treatment. A doible blinded control was carryed out. The main outcome messures were Visual Analogue Scale (VAS). The scondary outcome messures were Pressure Pain hreshold (PPT) and Active Range of Movement (ROM). Also psicologicla messures were taken, like Neck Dissability Index, Level of stress and ansiety, Fear Pain and Pain Avoidance Strategies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mechanical Neck pain of at least 6 months.
- • VAS 2 or greather.
- • Existance of miofascial trigger point in trapezius muscle assesed by an expert PT.
- Exclusion Criteria:
- • Neck pain due secondary to ostheoporosis, metastasis, neoplasias, fractures, infections, cervical stenosis or infexious procces.
- • Headache secondary to medular compression presenting one o the following signs: abnormal sensitivity, hiperreflexia, clonus, spread weakness, cervical hernia.
- • Neck pain with radiculopathy.
- • Whiplash.
- • Vertebrobasilar syndrome.
- • Dizzyness.
- • Pregnancy.
- • Having received dry needling treatment before.
About Universidad Rey Juan Carlos
Universidad Rey Juan Carlos (URJC) is a prominent academic institution located in Madrid, Spain, dedicated to advancing knowledge and research in various fields, including health sciences. With a commitment to innovation and excellence, URJC actively engages in clinical trials aimed at improving patient care and outcomes. The university's multidisciplinary approach fosters collaboration among researchers, clinicians, and industry partners, ensuring that its clinical research is grounded in scientific rigor and ethical standards. Through its robust infrastructure and expertise, Universidad Rey Juan Carlos is poised to contribute significantly to the advancement of medical research and the development of novel therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alcorcón, Madrid, Spain
Patients applied
Trial Officials
Jose Vicente León Hernández, PT
Principal Investigator
Universitdad Rey Juan Carlos
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials